Here is what participants achieved on average: Mounjaro (tirzepatide 15mg) SURMOUNT-1: Week 4: approximately 2 to 3% body weight loss Week 12: approximately 7 to 8% Week 24: approximately 13 to 15% Week 52: approximately 18 to 20% Week 72 (end of trial): average 20.9% Wegovy (semaglutide 2.4mg) STEP 1: Week 4: approximately 1 to 2% body weight loss Week 12: approximately 5 to 6% Week 24: approximately 9 to 10% Week 52: approximately 12 to 14% Week 68 (end of trial): average 14.9% These are averages
Degraded tirzepatide may not provide sufficient receptor activation
Treating people that have a normal BMI as if they are healthy by nature of that, I think, is a missed opportunity, he says
A large study of around 17,600 people showed that semaglutide injections reduced major cardiovascular events by 20% over a period of 3 years
The plateau that almost made me quit, and why I am glad I did not So this is the thing nobody warned me about
NICE guideline NG145 recommends monitoring TSH every 68 weeks after any change in levothyroxine dose, and then annually once stable